GlobeStar Therapeutics (GSTC) Price & Analysis

GSTC Stock Chart & Stats

$0.00-$0.00(-99.00%)

At close: Jul 22 9:30 AM EDT

Day’s Range: $0.01 - $0.01
52-Week Range: $0.01 - $0.02
Previous Close: $0.01
Volume: 2,275
Average Volume (3M): 8.39M
Market Cap: $1,241
Enterprise Value: $490.12B
Total Cash (Recent Filing): $41
Total Debt (Recent Filing): $329.05K
Price to Earnings (P/E): ―
Beta: 15.83
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

GSTC FAQ

What was GlobeStar Therapeutics’s price range in the past 12 months?

GlobeStar Therapeutics lowest stock price was $0.01 and its highest was $0.02 in the past 12 months.

What is GlobeStar Therapeutics’s market cap?

GlobeStar Therapeutics’s market cap is $1,241.

When is GlobeStar Therapeutics’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were GlobeStar Therapeutics’s earnings last quarter?

GlobeStar Therapeutics released its earnings results on Feb 15, 2018. The company reported -$0.009 earnings per share for the quarter.

Is GlobeStar Therapeutics overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does GlobeStar Therapeutics pay dividends?

GlobeStar Therapeutics does not currently pay dividends.

What is GlobeStar Therapeutics’s EPS estimate?

GlobeStar Therapeutics’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does GlobeStar Therapeutics have?

GlobeStar Therapeutics has 1,241,105,700 shares outstanding.

What happened to GlobeStar Therapeutics’s price movement after its last earnings report?

GlobeStar Therapeutics reported an EPS of -$0.009 in its last earnings report. Following the earnings report the stock price went same ―.

Which hedge fund is a major shareholder of GlobeStar Therapeutics?

Currently, no hedge funds are holding shares in GSTC

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description